|

An Oncology Nurse AI Agent to Reduce Cancer Distress During Radiotherapy

RECRUITINGN/ASponsored by The University of Hong Kong
Actively Recruiting
PhaseN/A
SponsorThe University of Hong Kong
Started2026-02-01
Est. completion2027-11
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The goal of this clinical trial is to assess the effectiveness of the Digi-Coach chatbot for reducing physical and psychological distress in people undergoing radiotherapy for head and neck cancer. The main question it aims to answer is: How effective is the Digi-Coach chatbot in reducing physical and psychological distress? Researchers will compare Digi-Coach chatbot to usual nursing care to see if Digi-Coach chatbot is effective for reducing physical and psychological distress in people undergoing radiotherapy for head and neck cancer. Participants will have access to the Digi-Coach chatbot during radiotherapy in addition to usual care. The research nurse will provide training on how to navigate the chatbot and ask participants to query all their cancer-related concerns in the chatbot.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* aged 18 and above
* are able to read and speak Cantonese or Mandarin fluently
* have a new, primary diagnosis of head and neck/laryngeal cancer
* are waiting to receive a full course of curative-intent, external beam radiotherapy with or without chemotherapy
* have a Karnofsky performance score ≥70
* have distress scored 3 or above on the NCCN distress thermometer

Exclusion Criteria:

* insufficient command of Chinese
* have any other factors precluding the ability to give informed consent or comply with the protocol

Conditions2

CancerHead and Neck Cancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.